共 81 条
- [1] Edelson, Tosteson Sax J.T.A.P., Cost-effectivcness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal bleeding, JAMA, 264, pp. 41-47, (1990)
- [2] Barrier C.H., Hirschowitz B.I., Controversies in the detection and management of nonsteroidal anti-inflammatory drug-induced side effects of the upper gastrointestinal tract, Arthritis Rheum, 32, pp. 926-932, (1989)
- [3] Langman M., Epidemiologic evidence on the association between peptic ulceration and anti-inflam-matorv drug use, Gastroenterology, 96, pp. 640-646, (1989)
- [4] Pincus T., Griffin M., Gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs: New insights from observational studies and functional status questionnaires, Am J Med, 91, pp. 209-212, (1991)
- [5] Larkai E.N., Smithlidsky J.L., Md Graham D.Y., Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use, Am J Gastroenterol, 82, pp. 1153-1158, (1987)
- [6] Armstrong C.P., Blower A.L., Non-ste-roidal anti-inflammatory drugs and life threatening complications of peptic ulceration, Gut, 28, pp. 527-532, (1987)
- [7] Isenberg J.L., Overview of clinical cy-toprotection, Dig Dis Sci, 30, pp. 815-825, (1985)
- [8] Wilson D.E., Role of prostaglandins in gastroduodenal mucosal protection, J Clin Gastroenterol, 13, pp. 65-71, (1991)
- [9] Soil A.H., Weinstein W.M., Kurata J., McCarthy D., Nonsteroidal anti-in-flammatory drugs and peptic ulcer disease, Ann Intern Med, 114, pp. 307-319, (1991)
- [10] Miller T.A., Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms, Am J Physiol, 245, pp. 601-623, (1983)